Wednesday, January 7, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Micron ...

Supermodel Bambi Northwood-Blyth wears a Dexcom glucose monitor. So does your next-door neighbor with type 2 diabetes and ...

Wearable health devices may soon operate under looser regulatory oversight following new guidance from the FDA ...

Dexcom (NSDQ:DXCM) today announced the beginning of new CEO Jake Leach's tenure, starting with his presence at CES 2026.

DexCom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, is ushering in the next era of transformative, ...

Global Technology Transfer Group (GTT Group), a global leader in patent analysis and transaction services, today announced the exclusive representation of a significant patent portfolio from a leading ...

Bank of America Securities analyst Travis Steed maintained a Buy rating on Dexcom today and set a price target of $100.00. According to TipRanks, Steed is a 4-star analyst with an average return of 7.

It has issued new guidance to clarify its regulatory approach on wearable devices. Read more at straitstimes.com. Read more ...

Lingo is Abbott’s over-the-counter continuous glucose monitor (CGM) for nondiabetic people. Withings users will also be able ...

This was the stock's second consecutive day of gains.

Now, it’s worth noting Stock Advisor’s total average return is 991 % — a market-crushing outperformance compared to 196% for ...

As the year comes to a close, it's time to look back at the numerous innovations across the diabetes technology industry in ...